Skip to main content
. 2007 Apr;148(1):112–118. doi: 10.1111/j.1365-2249.2007.03326.x

Table 1.

Baseline characteristics and clinical outcomes of patients with Kawasaki disease

Kawasaki patients Normal controls
Number 18 13
Male/female 11/7  9/4
Age (months) 24·2 ± 21·1 (range 3–12) 40·5 ± 33·7 (range 3–136)
Days of illness at initial IVIG  4·7 ± 1·2 (range 3–8)
Clinical symptoms
 6/6 10/18
 5/6  8/18
 4/6  0/18
Length of fever (days)  6·4 ± 2·9 (range 3–15)
Coronary artery lesions (+)  3/18

Data are presented as mean ± standard deviation. IVIG: intravenous immunoglobulin.